Abbott Laboratories
ABT · NYSE
Bulios Fair Price
$62.55
38.7% downside
Current Price
$101.96
According to Bulios Fair Price, ABT is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Abbott Laboratories (ABT) is an American healthcare company with a global presence. The company specializes in the development, manufacturing, and distribution of a wide range of healthcare products and medications. Abbott focuses on innovative pharmaceuticals, diagnostic equipment, medical devices, and nutritional products. Their portfolio includes products for various areas of healthcare, such as cardiovascular care, diabetes care, gastroenterology, infectious disease diagnostics, maternal and pediatric care, and many others. The company has a long history and is known for its quality, reliability, and research in healthcare innovations. Abbott Laboratories plays a crucial role in improving people's health worldwide and collaborates with physicians and healthcare professionals on the development of medications and diagnostic solutions. Abbott Laboratories (ABT) shares are an interesting choice for investors who follow the healthcare sector and seek investment opportunities in a key company operating in the healthcare industry.
Sector
Healthcare
Industry
Medical - Devices
CEO
Robert Ford
Employees
115,000
Headquarters
Abbott Park
Upcoming events
Earnings
Upcoming earnings report